Pharmaceuticals
United
States
Biopharmaceutical
Rare
Treatments
Development
M&A Advisory
Lazard
Full Credential Description
Achillion Pharmaceuticals. United States. Announced Date 06/08/2008. Closed Date 11/08/2008. Deal value: $42m. PIPE offering of common stock. Industry: Achillion Pharmaceuticals is a biopharmaceutical company focused on developing treatments for rare diseases.